Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

B Hajarizadeh, EB Cunningham, H Valerio… - Journal of …, 2020 - Elsevier
Background & Aims HCV reinfection following successful treatment can compromise
treatment outcomes. This systematic review assessed the rate of HCV reinfection following …

Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta‐analysis

SC Munari, MW Traeger, V Menon… - Liver …, 2023 - Wiley Online Library
Abstract Background & Aims Detecting hepatitis C virus (HCV) reinfection among key
populations helps prevent ongoing transmission. This systematic review aims to determine …

Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: current incidence rates …

P Ingiliz, MH Wehmeyer, C Boesecke… - Clinical Infectious …, 2020 - academic.oup.com
Background Micro-elimination of the hepatitis C virus (HCV) includes treatment in
populations at risk of ongoing HCV transmission, such as men who have sex with men …

[HTML][HTML] Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation

LA Kondili, A Aghemo, M Andreoni, M Galli… - Digestive and Liver …, 2022 - Elsevier
Although Italy has been on track for Hepatitis C Virus (HCV) elimination since 2019, it fell off
track due to the decrease in the number of treated patients. HCV elimination in Italy will be …

Reinfection and risk behaviors after treatment of hepatitis C virus infection in persons receiving opioid agonist therapy: a cohort study

J Grebely, GJ Dore, FL Altice, B Conway… - Annals of internal …, 2022 - acpjournals.org
Background: Hepatitis C virus (HCV) reinfection after successful treatment may reduce the
benefits of cure among people who inject drugs. Objective: To evaluate the rate of HCV …

Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people who inject drugs

EB Cunningham, B Hajarizadeh, J Amin… - Clinical Infectious …, 2021 - academic.oup.com
Background The aim of this analysis was to calculate the incidence of hepatitis C virus
(HCV) reinfection and associated factors among 2 clinical trials of HCV direct-acting antiviral …

Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway

H Midgard, K Ulstein, Ø Backe, T Foshaug… - International Journal of …, 2021 - Elsevier
Background The aims were to evaluate HCV treatment effectiveness, estimate reinfection
rates, and demonstrate the feasibility of reinfection surveillance and retreatment among …

[HTML][HTML] The impact of behavioural risk factors on communicable diseases: a systematic review of reviews

S Wood, SE Harrison, N Judd, MA Bellis, K Hughes… - BMC Public Health, 2021 - Springer
Abstract Background The coronavirus (COVID-19) pandemic has highlighted that individuals
with behavioural risk factors commonly associated with non-communicable diseases …

Mobile low-threshold buprenorphine integrated with infectious disease services

A Rosecrans, R Harris, RE Saxton, M Cotterell… - Journal of substance …, 2022 - Elsevier
Abstract Introduction In 2018, the Baltimore City Health Department launched a mobile clinic
called Healthcare on The Spot, which offers low-threshold buprenorphine services …

High rate of hepatitis C virus reinfection among recently injecting drug users: results from the TraP Hep C program—a prospective nationwide, population-based study

JM Johannesson, RH Fridriksdottir… - Clinical Infectious …, 2022 - academic.oup.com
Abstract Background The Treatment as Prevention for Hepatitis C program started in 2016 in
Iceland, offering treatment with direct-acting antivirals to hepatitis C virus (HCV)-infected …